Effectiveness of first-line abiraterone versus enzalutamide among patients ≥80 years of age with metastatic castration-resistant prostate cancer: A retrospective propensity score–weighted comparative cohort study
Titel:
Effectiveness of first-line abiraterone versus enzalutamide among patients ≥80 years of age with metastatic castration-resistant prostate cancer: A retrospective propensity score–weighted comparative cohort study
Auteur:
Soleimani, Maryam Zou, Kevin Sunderland, Katherine Struss, Werner Eigl, Bernie J. Nappi, Lucia Kollmannsberger, Christian K. Finch, Daygen Noonan, Krista Vergidis, Joanna Zulfiqar, Muhammad Chi, Kim N. Khalaf, Daniel J.